Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs

摘要

ObjectiveTo determine treatment patterns and costs over a two-year period among new initiators of topical prostaglandin analogs in a managed care population by retrospective cohort analysis of an insurance claims database.